Please login to the form below

Not currently logged in

Sanofi/Regeneron’s Dupixent successor underwhelms in phase 2

SanofiSuccess against placebo, but fails head-to-head

Celgene says no to Mereo’s cancer drug etigilimab

Celgene buildingUK biotech will focus on rare disease drugs

Syncona start-up Quell Therapeutics appoints chief exec

Quell TherapeuticsBiotech focusing on Tregs

EMD Serono allies with ‘free sequencing’ firm Nebula

Merck KGaAFree genomic sequencing in exchange for data use

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

TrulictyNovo looking to challenge with oral semaglutide

J&J takes option on Genmab follow-up to Darzalex

GenmabBlockbuster partners look to next chapter - while takeover talk persists

Merck & Co adds to immunotherapy again with $773m Tilos buy

Tilos TherapeuticsSpecialises in TGFβ complex-targeting therapies

Servier begins construction of new R&D hub in Paris

Servier constructionCentre to open by 2022

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts


Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...
Fearless Girl cover
25 women leaders in UK healthcare (part 2)